NasdaqGS - Nasdaq Real Time Price • USD
Accolade, Inc. (ACCD)
As of 3:21 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 10 | 15 | 10 |
| Avg. Estimate | -0.39 | -0.34 | -1.05 | -0.98 |
| Low Estimate | -0.48 | -0.45 | -1.95 | -1.29 |
| High Estimate | -0.24 | -0.19 | -0.18 | -0.69 |
| Year Ago EPS | -0.52 | -0.43 | -1.33 | -1.05 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 17 | 13 |
| Avg. Estimate | 110.38M | 114.6M | 492.92M | 581.72M |
| Low Estimate | 104.33M | 110.1M | 475.5M | 546.9M |
| High Estimate | 113.2M | 119.14M | 502.58M | 602.62M |
| Year Ago Sales | -- | -- | 414.29M | 492.92M |
| Sales Growth (year/est) | -- | -- | 19.00% | 18.00% |
Earnings History
| CURRENCY IN USD | 5/31/2023 | 8/31/2023 | 11/30/2023 | 2/29/2024 |
|---|---|---|---|---|
| EPS Est. | -0.62 | -0.54 | -0.44 | -0.07 |
| EPS Actual | -0.52 | -0.43 | -0.28 | -0.1 |
| Difference | 0.1 | 0.11 | 0.16 | -0.03 |
| Surprise % | 16.10% | 20.40% | 36.40% | -42.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.39 | -0.34 | -1.05 | -0.98 |
| 7 Days Ago | -0.39 | -0.34 | -1.13 | -0.98 |
| 30 Days Ago | -0.38 | -0.33 | -1.13 | -0.98 |
| 60 Days Ago | -0.37 | -0.33 | -1.12 | -0.99 |
| 90 Days Ago | -0.37 | -0.33 | -1.12 | -0.99 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ACCD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.00% | -- | -- | 1.50% |
| Next Qtr. | 20.90% | -- | -- | 12.10% |
| Current Year | 21.10% | -- | -- | 4.40% |
| Next Year | 6.70% | -- | -- | 13.20% |
| Next 5 Years (per annum) | -0.90% | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/26/2024 |
| Maintains | Truist Securities: Buy to Buy | 4/26/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 4/26/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/26/2024 |
| Maintains | Needham: Buy to Buy | 4/26/2024 |
| Maintains | Stifel: Buy to Buy | 4/22/2024 |
Related Tickers
PRVA Privia Health Group, Inc.
18.26
+1.50%
EVH Evolent Health, Inc.
27.72
-2.12%
OPRX OptimizeRx Corporation
10.07
+14.45%
STRM Streamline Health Solutions, Inc.
0.3183
-6.38%
HSTM HealthStream, Inc.
25.75
-0.66%
AUGX Augmedix, Inc.
2.7900
0.00%
HQY HealthEquity, Inc.
80.15
+1.40%
RCM R1 RCM Inc.
11.90
+0.63%
CMAX CareMax, Inc.
3.3000
+15.18%
PHR Phreesia, Inc.
20.83
+1.81%